Enzon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Cash & Equivalents	42.57	46.86	47.01	46.98	47.64	Upgrade
Cash & Short-Term Investments	42.57	46.86	47.01	46.98	47.64	Upgrade
Cash Growth	-9.14%	-0.33%	0.06%	-1.38%	-1.04%	Upgrade
Accounts Receivable	-	-	-	-	0.03	Upgrade
Receivables	-	-	-	-	0.03	Upgrade
Other Current Assets	0.24	0.29	0.33	0.41	0.09	Upgrade
Total Current Assets	42.81	47.15	47.34	47.39	47.75	Upgrade
Long-Term Deferred Tax Assets	-	0.02	0.36	0.2	-	Upgrade
Total Assets	42.81	47.17	47.7	47.59	47.75	Upgrade
Accounts Payable	0.33	0.33	0.33	0.33	0.33	Upgrade
Accrued Expenses	0.04	0.07	0.09	0.09	0.06	Upgrade
Other Current Liabilities	0.36	1.28	1.29	1.28	0.01	Upgrade
Total Current Liabilities	0.73	1.68	1.71	1.7	0.4	Upgrade
Total Liabilities	0.73	1.68	1.71	1.7	0.4	Upgrade
Common Stock	0.74	0.74	0.74	0.74	0.74	Upgrade
Additional Paid-In Capital	70.03	72.16	73.43	74.71	75.98	Upgrade
Retained Earnings	-73.3	-69.89	-70.67	-72.04	-71.86	Upgrade
Total Common Equity	-2.53	3.01	3.51	3.41	4.87	Upgrade
Shareholders' Equity	42.08	45.49	45.99	45.89	47.35	Upgrade
Total Liabilities & Equity	42.81	47.17	47.7	47.59	47.75	Upgrade
Net Cash (Debt)	42.57	46.86	47.01	46.98	47.64	Upgrade
Net Cash Growth	-9.14%	-0.33%	0.06%	-1.38%	-1.04%	Upgrade
Net Cash Per Share	0.57	0.63	0.63	0.63	0.64	Upgrade
Filing Date Shares Outstanding	74.21	74.21	74.21	74.21	74.21	Upgrade
Total Common Shares Outstanding	74.21	74.21	74.21	74.21	74.21	Upgrade
Working Capital	42.08	45.47	45.63	45.69	47.35	Upgrade
Book Value Per Share	-0.03	0.04	0.05	0.05	0.07	Upgrade
Tangible Book Value	-2.53	3.01	3.51	3.41	4.87	Upgrade
Tangible Book Value Per Share	-0.03	0.04	0.05	0.05	0.07	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.